IMDX — Insight Molecular Diagnostics Share News
0.000.00%
Last trade - 00:00- $92.61m
- $75.62m
- $4.06m
Brief: Oncocyte Corp Says Oncocyte's Vitagraft Kidney Transplant Diagnostic Test Receives CMS Coverage
OncoCyte Corp reports results for the quarter ended in June - Earnings Summary
OncoCyte Corp expected to post a loss of 87 cents a share - Earnings Preview
OncoCyte Corp expected to post a loss of 87 cents a share - Earnings Preview
Brief: Oncocyte Announces 1-For-20 Reverse Stock Split
Brief: Oncocyte Corp Begins Manufacturing Transplant Blood Test
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
OncoCyte Corp reports results for the quarter ended in March - Earnings Summary
Brief: Oncocyte Corp Reports Quarterly Earnings Per Share Of $0.02
Brief: OncoCyte Says CFO Anish John Will Be Leaving
OncoCyte Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: Oncocyte Announces Reduction In Force
Brief: Oncocyte Reports Preliminary Fourth Quarter Results
OncoCyte Corp expected to post a loss of 9 cents a share - Earnings Preview
OncoCyte Corp expected to post a loss of 9 cents a share - Earnings Preview
OncoCyte Corp expected to post a loss of 9 cents a share - Earnings Preview
Brief: OncoCyte Appoints Joshua Riggs As Chief Executive Officer
OncoCyte up on stock purchase deal, workforce reduction
Brief: OncoCyte Announces Reduction Of Workforce Over 40%